Our Story

Developing safer, more durable treatments
to improve the lives of patients

AltruBio is developing first-in-class immune-modulators to target diseases of the immune system. Its world-class global team brings a breadth of expertise in immunology and drug development to bring their biologic treatments to patients.  


Our Leadership

AltruBio’s senior management is built on a team of individuals possessing strong academic knowledge, high-level managerial experience and scientific expertise in a range of fields including life science, pharmacology, healthcare and immunology.

Judy Chou, Ph.D.

President and Chief Executive Officer

Jeroen Grasman

Chief Financial Officer

Jesse W. Hall, MD

Chief Medical Officer

Shih-Yao Lin, MD., Ph.D.

Vice President of Research

Gene Lee, Ph.D.

Vice President of Technical Development

Leewen Lin, Ph.D., LL.M.

Vice President of Legal Affairs

Simona Reed, Ph.D.

Vice President of Clinical Operations

Joseph S. McCracken, DVM, MS

Head of Business Development

Patrick Y. Yang, Ph.D.

Chairman of the Board

Judy Chou, Ph.D.

President and Chief Executive Officer

Sean P. Bohen, M.D., Ph.D.

John Doyle

Stephen G. Juelsgaard, D.V.M., J.D.

Gur Roshwalb, M.D.

Corsee Sanders, Ph.D.


Joseph B. Kirsner Professor of Medicine